$SGTX Sigilon Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Sigilon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sigilon Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Sigilon Therapeutics, Inc. for free.
IRS Number: 474005543
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SGTX
Company Address: 100 BINNEY STREET STE 600 CAMBRIDGE 02142
Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders, Lysosomal Storage Diseases, and Endocrine and Other Chronic Diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.
Sigilon Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | SGTX | Sigilon Therapeuti ... | Patel Kavita | Option Exercise | A | 9.97 | 8,888 | 88,613 | 8,888 | ||
Jun 28 2021 | SGTX | Sigilon Therapeuti ... | Cox John | Option Exercise | A | 9.97 | 8,888 | 88,613 | 8,888 | ||
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 1,481,481 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 370,370 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 4,074,074 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 1,481,481 | 0 | 1,481,481 | 0 to 1.5 M |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 8,888,888 | 0 | 8,888,888 | 0 to 8.9 M |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Cox John | Director | Option Exercise | C | 0.00 | 4,444 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Cox John | Director | Buy | C | 0.00 | 4,444 | 0 | 4,444 | 0 to 4.4 K |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Option Exercise | C | 0.00 | 22,222 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Buy | C | 0.00 | 22,222 | 0 | 22,222 | 0 to 22.2 K |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | ELI LILLY & Co | 10% Owner | Option Exercise | C | 0.00 | 888,888 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | ELI LILLY & Co | 10% Owner | Option Exercise | C | 0.00 | 1,555,555 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | ELI LILLY & Co | 10% Owner | Buy | P | 18.00 | 300,000 | 5,400,000 | 2,744,443 | 2.4 M to 2.7 M (+12.27 %) |